Ketamine induction and monoamine oxidase inhibitors
- PMID: 2271195
- DOI: 10.1016/0952-8180(90)90078-h
Ketamine induction and monoamine oxidase inhibitors
Abstract
A 42-year-old woman taking tranylcypromine, a monoamine oxidase (MAO) inhibitor, was hypovolemic from a ruptured ectopic pregnancy and required an emergency laparotomy. Anesthetic induction with ketamine, an agent with sympathomimetic properties, was used because of her hypovolemia, despite theoretical concerns of precipitating an adrenergic crisis. The patient's hemodynamic course remained unchanged with induction and intubation, and with further fluid and blood administration, satisfactory hemodynamic conditions were obtained. This report is believed to be the first to describe the use of ketamine in a patient taking MAO inhibitors.
Comment in
-
Monoamine oxidase inhibitors: are we condemned to relive history, or is history no longer relevant?J Clin Anesth. 1990 Sep-Oct;2(5):293-5. doi: 10.1016/0952-8180(90)90072-b. J Clin Anesth. 1990. PMID: 2271191 No abstract available.
Similar articles
-
Combination of intravenous S-ketamine and oral tranylcypromine in treatment-resistant depression: A report of two cases.Eur Neuropsychopharmacol. 2015 Nov;25(11):2183-4. doi: 10.1016/j.euroneuro.2015.07.021. Epub 2015 Aug 6. Eur Neuropsychopharmacol. 2015. PMID: 26302763
-
Antidepressant treatment with MAO-inhibitors during general and regional anesthesia: a review and case report of spinal anesthesia for lower extremity surgery without discontinuation of tranylcypromine.Int J Clin Pharmacol Ther. 2013 Oct;51(10):763-70. doi: 10.5414/CP201898. Int J Clin Pharmacol Ther. 2013. PMID: 23993253 Review.
-
Case of spontaneous splenic rupture caused by ectopic pregnancy in the spleen.J Obstet Gynaecol Res. 2017 Nov;43(11):1778-1780. doi: 10.1111/jog.13440. Epub 2017 Aug 1. J Obstet Gynaecol Res. 2017. PMID: 28762583
-
Cardiovascular collapse during anesthesia in a patient with preoperatively discontinued chronic MAO inhibitor therapy.J Clin Anesth. 1996 Dec;8(8):662-5. doi: 10.1016/s0952-8180(96)00175-4. J Clin Anesth. 1996. PMID: 8982896
-
Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression.Eur Neuropsychopharmacol. 2017 Aug;27(8):714-731. doi: 10.1016/j.euroneuro.2017.04.003. Epub 2017 Jun 1. Eur Neuropsychopharmacol. 2017. PMID: 28579071 Review.
Cited by
-
Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review.Int J Neuropsychopharmacol. 2021 Oct 23;24(10):808-831. doi: 10.1093/ijnp/pyab039. Int J Neuropsychopharmacol. 2021. PMID: 34170315 Free PMC article.
-
Next-Step Treatment Considerations for Patients With Treatment-Resistant Depression That Responds to Low-Dose Intravenous Ketamine.Focus (Am Psychiatr Publ). 2020 Apr;18(2):181-192. doi: 10.1176/appi.focus.20190048. Epub 2020 Apr 23. Focus (Am Psychiatr Publ). 2020. PMID: 33162856 Free PMC article.
-
Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editor.Gen Hosp Psychiatry. 2018 Sep-Oct;54:62-64. doi: 10.1016/j.genhosppsych.2018.05.007. Epub 2018 May 22. Gen Hosp Psychiatry. 2018. PMID: 30100209 Free PMC article. No abstract available.
-
Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study.CNS Drugs. 2021 Aug;35(8):881-892. doi: 10.1007/s40263-021-00837-6. Epub 2021 Jul 20. CNS Drugs. 2021. PMID: 34283390 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical